💊 Medicine & Health

GLP-1 Agonists (Ozempic) and Gas

Medications like Ozempic and Wegovy have transformed diabetes and weight management, but many users notice a surprising side effect: more gas and bloating. Here is the science behind why these drugs rearrange your digestive rhythm.

What Are GLP-1 Agonists?

GLP-1 receptor agonists are a class of injectable and oral medications that mimic glucagon-like peptide-1, a hormone the gut naturally releases after eating. Semaglutide (sold as Ozempic and Wegovy) is the best known, alongside liraglutide, dulaglutide and the dual GLP-1/GIP agonist tirzepatide. These drugs were developed to treat type 2 diabetes because they boost insulin release and curb glucagon, but they also powerfully reduce appetite, which made them blockbuster weight-loss treatments. A central part of how they work is slowing the rate at which the stomach empties its contents into the small intestine. That delayed gastric emptying keeps people feeling full for longer and blunts post-meal blood-sugar spikes, but it is also the root of most of the digestive side effects, including the extra wind that so many new users report. The class is expanding quickly, with newer agents and oral formulations such as Rybelsus widening how patients take them, so the number of people meeting these gut effects is growing fast.

Why They Trigger Gas and Bloating

The gas that comes with GLP-1 medications is largely a consequence of slowed digestion. When food lingers longer in the stomach and moves more slowly through the gut, there is more time for bacteria in the colon to ferment undigested carbohydrates, and fermentation is what produces hydrogen, methane and carbon dioxide. Slower intestinal transit can also promote bacterial overgrowth, giving those microbes even more opportunity to generate gas. On top of that, the nausea that commonly accompanies these drugs often leads to more air swallowing, or aerophagia, which adds swallowed nitrogen and oxygen to the mix. Because appetite suppression changes what and how much people eat, abrupt shifts toward high-fibre or high-protein foods can further amplify fermentation and odour while the gut adapts to its new, slower tempo. In short, the very slowdown that curbs hunger also hands the gut microbiome a longer, richer feast, and the by-products of that feast have to go somewhere.

How Common Is Flatulence on These Drugs?

Gastrointestinal complaints are the most frequent side effects of GLP-1 drugs, but isolated flatulence is actually fairly uncommon compared with nausea or diarrhoea. In pooled placebo-controlled trials summarised in the prescribing information for semaglutide, gastrointestinal adverse reactions overall were reported in roughly a third of treated patients versus about 15 percent on placebo, yet flatulence specifically was logged in only around 1 percent of participants. That gap matters: many people blame the drug for every rumble, but much of the perceived increase comes from constipation, altered stool and general bloating rather than a true surge in gas volume. Symptoms are most intense during the dose-escalation phase, when the dose is stepped up every few weeks, and they typically ease as the digestive system acclimatises to the medication over the following months. It is also worth remembering that trials capture flatulence only when patients report it as a distinct complaint, so real-world rates may sit somewhat higher than the label figures suggest.

Managing Gas While on GLP-1 Medications

The good news is that gas and bloating on GLP-1 medications are usually temporary and manageable. The single most effective strategy is slow dose titration: ramping up gradually gives the gut time to adjust and sharply reduces digestive complaints. Eating smaller, more frequent meals, chewing thoroughly, and avoiding large fatty or heavily carbonated meals all help, since these put less strain on a slowly emptying stomach. Increasing fibre gently rather than suddenly limits excess fermentation, and staying active supports normal motility. Over-the-counter options such as simethicone may ease trapped wind, while adequate hydration counters the constipation that often accompanies the gas. Persistent, severe or painful symptoms, or signs of true gastroparesis, should always be discussed with a prescribing clinician, who can adjust the dose or timing. Above all, patience helps: for most people the wind settles once the body has fully adjusted to a steady maintenance dose.

Did You Know?

Ozempic and Wegovy are the same drug, semaglutide, just branded and dosed differently for diabetes versus weight loss.
Flatulence was logged in only about 1 percent of participants in semaglutide trials, far less than nausea.
The slowed stomach emptying that causes gas is the very same effect that makes these drugs so good at reducing appetite.
Digestive side effects peak during dose escalation and usually fade as the body adapts.

Fun Fact

The appetite-crushing power of GLP-1 drugs and their windy side effects come from one and the same mechanism: a stomach that has decided to take its time.

Sources

U.S. Food and Drug Administration (2017). Highlights of Prescribing Information: Ozempic (semaglutide) injection.
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (2021). Symptoms & Causes of Gas in the Digestive Tract.
Feldman, M., Friedman, L.S. & Brandt, L.J. (eds.) (2020). Sleisenger and Fordtran's Gastrointestinal and Liver Disease, 11th ed. Elsevier.

Created with AI assistance based on the scientific sources listed. Not a substitute for medical advice.

Go to Gallery 💨